We are excited to announce that this year's Plasma Protein Forum is November 19-20! Registration opens in one month on September 9. Bookmark the event page here:
This content isn’t available here
Access this content and more in the LinkedIn app
The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. As a trusted partner to health systems, PPTA drives broad and reliable access to plasma derived medicinal products with a focus on the well-being of patients and plasma donors. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions. PPTA works globally to: • Advocate for access to and affordability of therapies for patients • Engage in constructive dialogue with regulatory agencies • Collaborate with patient advocacy organizations PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients. PLASMA AVAILABILITY • Responsibly Improve the Reliable Availability of Plasma • Advocate for global sufficiency of plasma • Pioneer plasma safety and manufacturing quality and support donor well-being • Drive progressive policies for plasma collections ACCESS TO THERAPIES • Advocate for Patient Access to Plasma Protein Therapies • Promote clinician authority and patient participation in treatment • decisions • Pursue reimbursement models recognizing the unique nature of plasma protein therapies • Shape decisions of authorities to improve plasma protein therapy availability • Forage partnerships that support patient-focused initiatives AWARENESS • Advance the Understanding of the Plasma Ecosystem • Encourage plasma donation globally • Generate and promote evidence-based information about plasma • Explain the importance, unique nature, and value of plasma protein therapies
External link for Plasma Protein Therapeutics Association (PPTA)
147 Old Solomons Island Road
Suite 100
Annapolis, MD 21401, US
How will the outcome of the upcoming elections affect the plasma industry? Join former Congressman Kurt Schrader (D-OR), Axios Health Correspondent Victoria Knight, and Republican strategist Alec Aramanda for a timely discussion of the election results and potential ramifications at the #PlasmaProteinForum. Register today: PPTAGlobal.org/Forum
PPTA staff was pleased to attend the Brazilian Congress of Hematology, Hemotherapy, and Cellular Therapy last week in Sao Paolo, Brazil. PPTA's Joshua Penrod presented on EU and US regulatory frameworks for the collection of plasma, and also discussed the ethical debate surrounding donor compensation. The conference had more than 8,000 attendees from Latin America and other regions, and had sponsored sessions relating to many aspects of hematology, including rare diseases, oncology, and improvements in treatment and technology. ABHH Oficial #ABHH #ABHHOficial #HEMO #HEMO2024 #CongressoHEMO #SaoPaolo
Alpha-1 Awareness Month starts next week. Do you know the signs to look for? Visit https://lnkd.in/ee8tSy4w to learn more. Alpha-1 Foundation
Boost your brand and connect with thousands! Have your company seen by healthcare providers, patients, and industry specialists at the 32nd Plasma Protein Forum. Choose between our Digital Promotion Package, Meeting App, or Advertising E-blast. Make your mark and sign up by October 30 at PPTAGlobal.org/Forum. Don't miss out!
Plasma Protein Therapeutics Association (PPTA) reposted this
The voice of plasma-derived medicines needs to be heard. Kedrion is actively working with our trade association, Plasma Protein Therapeutics Association (PPTA) to ensure access to therapies through a well-functioning ecosystem that includes plasma collection and fractionation. Our industry’s uniqueness enables millions of patients to receive treatment and lead normal lives. Yesterday, PPTA President Anita Brikman and our Chief Communications Officer, Duccio Manetti, PhD met in New York to discuss the future of the industry and ongoing initiatives with policymakers and key stakeholders. “Kedrion is grateful to PPTA and Anita for the renewed energy and commitment our trade association brings to the industry. Only through their support can we ensure all players continue to operate in a sustainable, patient-centered way“ - Duccio Manetti
Hear from Anthony Castaldo, CEO and Chairman of the Board, Hereditary Angioedema Association - HAEA and HAE International, at this year’s #PlasmaProteinForum! The HAEA & HAEi represent people suffering from hereditary angioedema. These teams of highly motivated advocates focus on making a positive and measurable impact on quality of life by providing extensive programs, educational resources, and hands-on assistance that help people with HAE win access to and reimbursement for the HAE therapy prescribed by their physician. Click here to sign up: https://lnkd.in/e_jZPZSd
Attention #medicalprofessionals and #HCPs: The Albumin Learning Network is a special online platform specifically created so that you can learn more about albumin and its various medical uses. Join today for free at albuminlearningnetwork.org.
Congratulations to the following plasma centers on achieving IQPP certification! IQPP provides independent, third-party evaluation and recognition of a center's adherence to global industry standards for source plasma. Click here to learn more: https://lnkd.in/eFTi4kHq